Several other equities research analysts have also recently commented on MON. Zacks Investment Research cut Monsanto from a buy rating to a hold rating in a research note on Monday, December 11th. Royal Bank of Canada reissued a hold rating and issued a $128.00 target price on shares of Monsanto in a research note on Wednesday, November 15th. Macquarie cut Monsanto from an outperform rating to a neutral rating in a research note on Wednesday, October 4th. Wells Fargo & Co lifted their target price on Monsanto from $107.50 to $118.00 and gave the company a market perform rating in a research note on Tuesday, October 10th. Finally, BMO Capital Markets reissued a buy rating and issued a $128.00 target price on shares of Monsanto in a research note on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Monsanto has an average rating of Hold and a consensus target price of $127.30.
Monsanto (MON) opened at $120.66 on Tuesday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79. Monsanto has a 52-week low of $106.97 and a 52-week high of $122.79. The stock has a market capitalization of $53,110.00, a price-to-earnings ratio of 22.30, a price-to-earnings-growth ratio of 1.70 and a beta of 1.04.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.77 billion. During the same quarter in the previous year, the firm posted $0.21 EPS. The company’s revenue for the quarter was up .3% compared to the same quarter last year. equities research analysts expect that Monsanto will post 5.76 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a $0.54 dividend. The ex-dividend date is Thursday, January 4th. This represents a $2.16 annualized dividend and a dividend yield of 1.79%. Monsanto’s dividend payout ratio (DPR) is currently 39.93%.
In related news, EVP Steven Mizell sold 8,100 shares of Monsanto stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the sale, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.79% of the stock is currently owned by company insiders.
Several institutional investors have recently made changes to their positions in the stock. MML Investors Services LLC grew its stake in shares of Monsanto by 0.6% during the second quarter. MML Investors Services LLC now owns 10,281 shares of the basic materials company’s stock worth $1,217,000 after purchasing an additional 57 shares during the period. Scotia Capital Inc. grew its stake in shares of Monsanto by 1.6% during the second quarter. Scotia Capital Inc. now owns 3,765 shares of the basic materials company’s stock worth $446,000 after purchasing an additional 60 shares during the period. FTB Advisors Inc. grew its stake in shares of Monsanto by 5.5% during the second quarter. FTB Advisors Inc. now owns 2,415 shares of the basic materials company’s stock worth $286,000 after purchasing an additional 126 shares during the period. Fort Washington Investment Advisors Inc. OH grew its stake in shares of Monsanto by 0.9% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 24,877 shares of the basic materials company’s stock worth $2,944,000 after purchasing an additional 210 shares during the period. Finally, Advisor Group Inc. grew its stake in shares of Monsanto by 1.1% during the second quarter. Advisor Group Inc. now owns 21,924 shares of the basic materials company’s stock worth $2,588,000 after purchasing an additional 238 shares during the period. 75.37% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Monsanto (MON) Earns Buy Rating from Deutsche Bank” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://ledgergazette.com/2018/01/20/monsanto-mon-earns-buy-rating-from-deutsche-bank.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.